The Developmental Therapeutics Program at Cohen Children’s works to identify novel agents in the treatment of childhood cancer and blood disorders and offers our patients new and innovative treatment options. In addition to clinical trials run by our own physicians and scientists, we also participate in national clinical trials through cooperative groups such as the Children’s Oncology Group (COG).
The Developmental Therapeutics Program offers Phase 1 and other early-phase clinical trials for a wide range of children’s cancers. We work closely with referring physicians and families to identify appropriate options for each individual child and to support the child and the whole family through the entire treatment process.
The goals of the Developmental Therapeutics Program include:
- Improving the outcomes of children, adolescents and young adults with cancer through clinical trials of new investigational agents and regimens
- Working with patients, families and their medical team to determine if participation in a clinical trial of an investigational agent or new treatment approach is right for a child
The Developmental Therapeutics Program is currently involved in clinical trials regarding brain tumors, solid tumors, leukemia/lymphoma, bone marrow failure, bone marrow transplants and hemostasis/thrombosis.
You can find more information about our clinical trials here.